Success Story: NIW Approved Without an RFE for a Biomedical Informatics Researcher
Client’s Testimonial:
"Thank you very much for your congratulations and for your guidance throughout my NIW I-140 process. I truly appreciate your team’s professionalism and support.”
On January 31st, 2026, we received another EB-2 NIW (National Interest Waiver) approval for a Research Faculty in the Field of Biomedical Informatics (Approval Notice).
General Field: Biomedical Informatics
Position at the Time of Case Filing: Research Faculty
Approval Notice Date: January 31st, 2026
Processing Time: 4 months, 20 days (Premium Processing Upgrade Requested)
Case Summary:
North America Immigration Law Group (Chen Immigration Law Associates) is pleased to share an I-140 EB-2 NIW (National Interest Waiver) approval for the client, a researcher specializing in the development and application of advanced artificial intelligence methods to improve disease detection, clinical decision support, and healthcare efficiency. The proposed endeavor focuses on enhancing early identification and management of serious medical conditions through data-driven approaches. The petition presented the endeavor as nationally important because it targets conditions where earlier signals and better decision support can meaningfully improve outcomes and reduce strain on healthcare delivery systems across the United States.
Accomplishments and Expertise The client holds a doctoral degree and has developed expertise in applying computational and data science techniques to complex biomedical challenges. The proposed endeavor is to continue developing and implementing AI methods that support earlier and more accurate disease detection and management, enabling more personalized therapies and improving healthcare efficiency. In the petition, we emphasized that this work is not limited to a single narrow dataset or tool. Instead, the client’s research integrates AI across multiple data streams, including imaging, multi-omics, harmonized electronic health records, and physiological signals, which strengthens clinical usability across more than one disease area.
The petition also documented that the client currently works in a faculty research role at a U.S.-based school, providing a clear platform for continuing research and publishing in the same technical direction.
Objective Evidence of Independent Validation For NIW, metrics cannot be treated as self-proving. The question is whether the record shows field-recognized momentum and a credible ability to keep advancing the endeavor. We highlighted objective indicators and then tied them to how the research community signals value and trust:
- 10 peer-reviewed journal articles (including 1 first-authored and 3 co-first-authored), 1 peer-reviewed conference article, and 4 abstracts (including 1 first-authored)
- 83 citations to the client’s published body of work
- At least 14 completed peer reviews
NIW Approval and Outlook USCIS approved the NIW petition without an RFE, reflecting a case presentation that clearly connected the endeavor to national-scale healthcare needs and demonstrated that the client is well-positioned through a sustained research record, measurable independent reliance, and documented peer-review trust. Our firm congratulates the client on this milestone and looks forward to the client’s continued contributions to clinically meaningful AI that improves patient outcomes and strengthens healthcare delivery across the United States.

